Nikolaos D. Karakousis, Konstantinos I. Gourgoulianis, O. Kotsiou
{"title":"肺栓塞与肌肉疏松症:潜在的相互作用","authors":"Nikolaos D. Karakousis, Konstantinos I. Gourgoulianis, O. Kotsiou","doi":"10.18332/pne/183959","DOIUrl":null,"url":null,"abstract":"and other healthcare professionals to diagnose PE and VTE 1,6,7 . Concerning the management of PE and treatment implementation, primary reperfusion treatment, which usually includes systemic thrombolysis, is the therapy of choice for subjects with increased risk for PE, while surgical pulmonary embolectomy or percutaneous catheter-directed therapy are other reperfusion techniques and choices in subjects who cannot sustain thrombolysis 8,9 . In addition, following reperfusion therapy and hemodynamic stabilization of the patient, subjects recovering from high-risk PE can be redirected from parenteral to oral anticoagulation 8 . In cases of intermediate-risk and low-risk PE, anticoagulant treatment is appropriate 8 . Sarcopenia is a skeletal muscle mass condition that might be progressive and can be related to both skeletal muscle mass and muscle function, associated with many adverse clinical results, such as falls, disability, hospitalizations, ABSTRACT","PeriodicalId":42353,"journal":{"name":"Pneumon","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pulmonary embolism and sarcopenia: The potential\\ninterplay\",\"authors\":\"Nikolaos D. Karakousis, Konstantinos I. Gourgoulianis, O. Kotsiou\",\"doi\":\"10.18332/pne/183959\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"and other healthcare professionals to diagnose PE and VTE 1,6,7 . Concerning the management of PE and treatment implementation, primary reperfusion treatment, which usually includes systemic thrombolysis, is the therapy of choice for subjects with increased risk for PE, while surgical pulmonary embolectomy or percutaneous catheter-directed therapy are other reperfusion techniques and choices in subjects who cannot sustain thrombolysis 8,9 . In addition, following reperfusion therapy and hemodynamic stabilization of the patient, subjects recovering from high-risk PE can be redirected from parenteral to oral anticoagulation 8 . In cases of intermediate-risk and low-risk PE, anticoagulant treatment is appropriate 8 . Sarcopenia is a skeletal muscle mass condition that might be progressive and can be related to both skeletal muscle mass and muscle function, associated with many adverse clinical results, such as falls, disability, hospitalizations, ABSTRACT\",\"PeriodicalId\":42353,\"journal\":{\"name\":\"Pneumon\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2024-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pneumon\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18332/pne/183959\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumon","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18332/pne/183959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
1,6,7 。在 PE 的管理和治疗实施方面,对于 PE 风险增加的患者,首选的治疗方法是初级再灌注治疗,通常包括全身溶栓治疗;而对于无法承受溶栓治疗的患者,可选择外科肺栓塞切除术或经皮导管引导治疗等其他再灌注技术 8,9 。此外,在再灌注治疗和患者血流动力学稳定后,从高风险 PE 恢复的患者可从肠外抗凝转为口服抗凝 8 。在中危和低危 PE 病例中,抗凝治疗是适当的 8 。肌肉疏松症是一种骨骼肌质量问题,可能是渐进性的,与骨骼肌质量和肌肉功能都有关系,与许多不良临床结果有关,如跌倒、残疾、住院、ABSTRACT[摘要]。
Pulmonary embolism and sarcopenia: The potential
interplay
and other healthcare professionals to diagnose PE and VTE 1,6,7 . Concerning the management of PE and treatment implementation, primary reperfusion treatment, which usually includes systemic thrombolysis, is the therapy of choice for subjects with increased risk for PE, while surgical pulmonary embolectomy or percutaneous catheter-directed therapy are other reperfusion techniques and choices in subjects who cannot sustain thrombolysis 8,9 . In addition, following reperfusion therapy and hemodynamic stabilization of the patient, subjects recovering from high-risk PE can be redirected from parenteral to oral anticoagulation 8 . In cases of intermediate-risk and low-risk PE, anticoagulant treatment is appropriate 8 . Sarcopenia is a skeletal muscle mass condition that might be progressive and can be related to both skeletal muscle mass and muscle function, associated with many adverse clinical results, such as falls, disability, hospitalizations, ABSTRACT